DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the ONESOURCE SPECL PHARMA L (ONESOURCE) share price today?

ONESOURCE SPECL PHARMA L (ONESOURCE) is trading at ₹1,653.2 on the NSE, up 0.24% on the day. Source: DocStoX.

What is the market capitalisation of ONESOURCE SPECL PHARMA L?

ONESOURCE SPECL PHARMA L has a market capitalisation of approximately ₹18,766 crore.

ONESOURCE SPECL PHARMA L

ONESOURCE·NSE·Healthcare

₹1,653.20▲ +4.00 (+0.24%)

Healthcare · Pharmaceuticals

Revenue compounding 232% a year

NIFTY 500NIFTY SMALLCAP 250

Day₹1625.50

₹1665.00

52W₹1057

₹202761%

Open

₹1660.00

High

₹1665.00

Low

₹1625.50

Prev Close

₹1649.20

Volume

1.90L

VWAP

₹1646.40

Snapshot

Key fundamentals

Market Cap

₹18,766 Cr

P/E Ratio

N/A

P/B Ratio

3.32

EPS

₹-6.44

Book Value

₹509.00

ROE

-1.09%Weak

ROCE

1.00%Weak

Dividend Yield

0.00%

Debt / Equity

0.26Low

Face Value

₹1.00

52W High

₹2026.50

52W Low

₹1057.00

Sector

Healthcare

Industry

Pharmaceuticals

Avoid

None moatHigh uncertainty

Fair value estimate

₹428

▼ 74.1%downside

Trading at ₹1,653 — 74% above our estimate

BearFair valueBull

₹364₹428₹492

/100

Business quality — Watch the fundamentals

Growth 100Profitability 0Efficiency 0Valuation 87

Plain English

Our view

Revenue compounding 232% a year
Low debt relative to equity
Weak returns on equity (-1%)

Strengths

Low debt relative to equity
Revenue compounding 232% over 3 years

Risks

Weak returns on equity (-1%)
Fundamental red flags (Piotroski 1/9)

How we got there

Fair value methods

Residual income

-1% ROE fading to 12% over ~3 yrs, on ₹509 book

₹428

Relative P/E

Needs positive EPS

—

Graham floor

Needs positive EPS

—

Analyst target

No analyst coverage

—

Blended fair value₹428

What the numbers say

Investment thesis

Bull case

Low debt relative to equity
Revenue compounding 232% over 3 years

Bear case

Weak returns on equity (-1%)
Fundamental red flags (Piotroski 1/9)

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

—

ROE

-1.1%Weak

Above 15% is considered healthy for Indian equities

ROCE

1.0%Weak

Above 18% means capital is working hard

Debt/Eq

0.26Low

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹18,766 Cr

P/B

3.32

EPS

₹-6.44

Div Yield

—

What changed

Recent changes

Foreign investors-1.7% stake last quarter
Domestic institutions+1.8% stake last quarter
Promoters+0.55% stake last quarter

What matters

News impact

Overview

Valuation

N/A

No P/E

Growth

Strong

+232% rev CAGR

Profitability

Loss-making

-1.1% ROE

Financial health

Rock solid

D/E 0.26

Momentum

N/A

No technicals

Today

Trading activity

Delivery %53.4%

Turnover₹3129.02L Cr

Trades16,903

VWAP₹1646.40

Face value₹1.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

+231.6%

+132.3%

10Y

—

Profit

—

10Y

—

EPS

—

10Y

—

Profile

Cons

Stock is trading at 3.20 times its book value
Company has low interest coverage ratio.
Company has a low return on equity of -2.39% over last 3 years.
Promoters have pledged 38.4% of their holding.
Company has high debtors of 177 days.

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 31 Mar 2026

Promoters raised their stake by 0.55 pts; foreign investors sold 1.74 pts; domestic institutions added 1.80 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

30%

Promoter

Promoters

30.5%+0.55

Public

12.2%-0.21

FII / FPI

17.5%-1.74

DII

20.6%+1.80

Others

19.2%

Total shareholders

79,460-5,135 QoQ

Quarterly trend

Ownership over time

Q4 FY26

Promoter30.48%

FII17.50%

DII20.61%

Public12.18%

Others19.23%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions